 |
|
|
PRGO Description — Perrigo Company plc
Perrigo Co. plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the U.S. and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Co..
| Company Name: |
Perrigo Company plc |
| Website: |
www.perrigo.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding PRGO: |
122 |
| Total Market Value Held by ETFs: |
$1,340,111,155.92 |
| Total Market Capitalization: |
$3,418,000,000 |
| % of Market Cap. Held by ETFs: |
39.21% |
|
| ETF |
PRGO Weight |
PRGO Amount |
| BTAL |
148.69% |
$513,878,253 |
| IJH |
0.11% |
$109,884,693 |
| VTI |
0.01% |
$105,249,776 |
| VB |
0.05% |
$85,418,304 |
| VBR |
0.09% |
$57,813,353 |
| VXF |
0.04% |
$50,741,272 |
| SDY |
0.22% |
$42,884,191 |
| REGL |
2.10% |
$33,053,622 |
| MDY |
0.11% |
$27,858,863 |
| SMIG |
2.98% |
$22,535,733 |
| List of all 122 ETFs holding PRGO
» |
|
|
|
|
|
Buy (3.00 out of 4)
21st percentile
|
PARTNER NEWS:Wed, Nov 6, 10:59 AM, Zacks
Perrigo's Q3 Earnings Fall Short of Estimates, Sales View Updated
PRGO reports weaker-than-expected third-quarter 2024 results. Though management updates top-line guidance for 2024, it reaffirms the bottom-line outlook.
Wed, Nov 6, 6:40 AM, Zacks
Perrigo (PRGO) Q3 Earnings and Revenues Lag Estimates
Perrigo (PRGO) delivered earnings and revenue surprises of -1.22% and 2.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
|
|
Free PRGO Email Alerts:
